Lanreotide in Patients with Lung Neuroendocrine Tumors: The Randomized Double-Blind Placebo-Controlled International Phase 3 SPINET Study

被引：5
|
作者：
Reidy-Lagunes, Diane [1 ]
Kulke, Michael [2 ]
Wolin, Edward [3 ]
Singh, Simron [4 ]
Ferone, Diego [5 ]
Hoersch, Dieter [6 ]
Mirakhur, Beloo [7 ]
Hoffmanns, Philipp [8 ]
Houchard, Aude [8 ]
Caplin, Martyn [9 ]
Baudin, Eric [10 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Montefiore Einstein Ctr Canc Care, Bronx, NY USA
[4] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[5] Irccs Azienda Osped Univ San Martino, Ist Ist Nazl Ric Canc, Genoa, Italy
[6] Zentralklin Bad Berka, Bad Berka, Germany
[7] Ipsen, Basking Ridge, NJ USA
[8] Ipsen, Boulogne Billancourt, France
[9] Royal Free Hosp, London, England
[10] Gustave Roussy Canc Campus, Villejuif, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Lung neuroendocrine tumors; Lanreotide; Progression-free survival;
D O I：
10.1016/j.jtho.2016.11.2090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB119
引用
收藏
页码：S1516 / S1517
页数：2
相关论文
共 50 条
  • [1] Lanreotide autogel/depot in lung neuroendocrine tumours: The randomized, double-blind, placebo-controlled, international phase 3 SPINET Study
    Thanh, X-M. Truong
    Reidy-Lagunes, D.
    Kulke, M.
    Wolin, E.
    Singh, S.
    Ferone, D.
    Hoersch, D.
    Houchard, A.
    Caplin, M.
    Baudin, E.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S138 - S139
  • [2] SPINET: A Randomized, Double-blind, Placebo-controlled Phase III Study of Lanreotide Autogel/Depot (LAN) in Patients with Advanced Lung Neuroendocrine Tumors
    Reidy-Lagunes, Diane
    Kulke, Matthew
    Wolin, Edward
    Singh, Simron
    Ferone, Diego
    Mirakhur, Beloo
    Hoffmanns, Philipp
    Houchard, Aude
    Caplin, Martyn
    Baudin, Eric
    PANCREAS, 2017, 46 (03) : 451 - 451
  • [3] Lanreotide Autogel/ Depot (LAN) in Lung Neuroendocrine Tumours (NETs): The Randomized, Double-Blind, Placebo (PBO)-Controlled, International Phase 3 SPINET Study
    Reidy-Lagunes, D.
    Kulke, M. H.
    Wolin, E. M.
    Singh, S.
    Ferone, D.
    Hoersch, D.
    Mirakhur, B.
    Hoffmanns, P.
    Houchard, A.
    Caplin, M.
    Baudin, E.
    NEUROENDOCRINOLOGY, 2017, 105 : 209 - 209
  • [4] A randomized, double-blind, placebo-Controlled study of Lanreotide Antiproliferative Response in patients with gastroenteropancreatic NeuroEndocrine Tumors (CLARINET)
    Caplin, M.
    Ruszniewski, P.
    Pavel, M.
    Cwikla, J.
    Phan, A.
    Raderer, M.
    Sedlackova, E.
    Cadiot, G.
    Wall, L.
    Rindi, G.
    Liyanage, N.
    Blumberg, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S3 - S3
  • [5] Safety and efficacy of lanreotide depot/autogel (LAN) in patients with lung NETs: The randomized, double-blind, placebo (PBO)-controlled phase III SPINET study.
    Reidy, Diane Lauren
    Kulke, Matthew H.
    Wolin, Edward M.
    Singh, Simron
    Ferone, Diego
    Mirakhur, Beloo
    Massien, Christine
    Houchard, Aude
    Caplin, Martyn E.
    Baudin, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Design of a Phase 2, Prospective, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Lanreotide Depot 120 mg in Patients With Well Differentiated, Advanced Lung, or Thymus Neuroendocrine Tumors (NETs)
    Reidy-Lagunes, Diane
    Wolin, Edward M.
    Pitman-Lowenthal, Susan
    Cox, David
    Kulke, Matthew H.
    PANCREAS, 2016, 45 (03) : 480 - 481
  • [7] Daridorexant in Japanese patients with insomnia disorder: A phase 3, randomized, double-blind, placebo-controlled study
    Uchimura, Naohisa
    Taniguchi, Mitsutaka
    Ariyoshi, Yu
    Oka, Yasunori
    Togo, Osamu
    Uchiyama, Makoto
    SLEEP MEDICINE, 2024, 122 : 27 - 34
  • [8] Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study
    Motoya, Satoshi
    Watanabe, Kenji
    Ogata, Haruhiko
    Kanai, Takanori
    Matsui, Toshiyuki
    Suzuki, Yasuo
    Shikamura, Mitsuhiro
    Sugiura, Kenkichi
    Oda, Kazunori
    Hori, Tetsuharu
    Araki, Takahiro
    Watanabe, Mamoru
    Hibi, Toshifumi
    PLOS ONE, 2019, 14 (02):
  • [9] Lanreotide reduces the volume of polycystic liver: A randomized, double-blind, placebo-controlled trial
    Van Keimpema, Loes
    Nevens, Frederik
    Vanslembrouck, Ragna
    Van Oijen, Martijn G. H.
    Hoffmann, Aswin L.
    Dekker, Helena M.
    De Man, Robert A.
    Drenth, Joost P. H.
    GASTROENTEROLOGY, 2009, 137 (05) : 1661 - 1668
  • [10] Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study
    Taslimi, Shervin
    Vahidi, Hamed
    Pourvaziri, Ali
    Modabbernia, Amirhossein
    Fallah, Arezoo Yeke
    Yazdani, Nasrin
    Taslimi, Negin
    Hosseini, Mostafa
    Zarandi, Masoud Motesadi
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2013, 270 (05) : 1635 - 1641
12345